An evidence-based review of insomnia treatment in early recovery

Journal of Addiction Medicine

Volumn 8, Issue 6, 2014, Pages 389-394

  Kaplan, Katherine A ^a   McQuaid, John ^b,c   Primich, Charles ^c   Rosenlicht, Nicholas ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Abstinence; Cognitive behavioral therapy; Insomnia; Recovery; Sleep

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; DOXEPIN; ESZOPICLONE; GABAPENTIN; NEUROLEPTIC AGENT; PLACEBO; PRAZOSIN; QUETIAPINE; RAMELTEON; TRAZODONE; ZALEPLON; ZOLPIDEM; HYPNOTIC SEDATIVE AGENT;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ANXIETY DISORDER; COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; CONVALESCENCE; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG EFFICACY; ENERGY; EPWORTH SLEEPINESS SCALE; EVIDENCE BASED PRACTICE; EXERCISE; HUMAN; INSOMNIA; INSOMNIA SEVERITY INDEX; LOW DRUG DOSE; MENTAL DISEASE; MOUTH HYGIENE; NONHUMAN; ONSET AGE; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PIITTSBURGH SLEEP QUALITY INDEX; POPULATION RESEARCH; PREBEDTIME EXERCISE; PREDICTION; PRESCRIPTION; PSYCHOEDUCATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REM SLEEP; REVIEW; RISK FACTOR; SELF REPORT; SITTING; SLEEP DEPRIVATION; SLEEP DIARIES; SLEEP HYGIENE; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; STIMULUS RESPONSE; SUBSTANCE ABUSE; TREATMENT INDICATION; COMPLICATION; EVIDENCE BASED MEDICINE; RECURRENT DISEASE; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE-RELATED DISORDERS;

COGNITIVE THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; HYPNOTICS AND SEDATIVES; RECURRENCE; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 84921990231     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000052     Document Type: Review

References (69)

1. Armitage R. Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand Suppl. 2007;(433):104-115. doi:ACP968[pii]10.1111/j.1600-0447.2007.00968.x.
2. Arnedt JT, Conroy DA, Armitage R, et al. Cognitive-behavioral therapy for insomnia in alcohol dependent patients: A randomized controlled pilot trial. Behav Res Ther. 2011;49(4):227-233. doi:10.1016/j.brat.2011.02.003.
3. Arnedt JT, Conroy D, Rutt J, et al. An open trial of cognitive-behavioral treatment for insomnia comorbid with alcohol dependence. Sleep Med. 2007;8(2):176-180. doi:10.1016/j.sleep.2006.06.007.
4. Baekeland F, Lundwall L, Shanahan TJ, et al. Clinical correlates of reported sleep disturbance in alcoholics. Q J Stud Alcohol. 1974;35(4) (Pt A):1230-1241.
5. Bastien CH,Vallieres A, Morin CM.Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297-307. doi:S1389945700000654 [pii].
6. Bootzin RR. Stimulus control treatment for insomnia. Proc Am Psychol Assoc. 1972;7:395-396.
7. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biol Psychiatry, 1996;39(6):411-418.
8. Brower KJ. Alcohol's effects on sleep in alcoholics. Alcohol Res Health. 2001;25(2):110-125.
9. Brower KJ. Insomnia, alcoholism and relapse. Sleep Med Rev. 2003;7(6):523-539.
10. Brower KJ, Aldrich MS, Robinson EA, et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry. 2001;158(3):399-404.
11. Brower KJ,MyraKim H, Strobbe S, et al.Arandomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res. 2008;32(8):1429-1438. doi:ACER706 [pii] 10.1111/j.1530-0277.2008.00706.x.
12. Budney AJ, Moore BA, Vandrey RG, et al. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112(3):393-402.
13. Burke CK, Peirce JM, Kidorf MS, et al. Sleep problems reported by patients entering opioid agonist treatment. J Subst Abuse Treat. 2008;35(3):328-333. doi:S0740-5472(07)00324-8 [pii] 10.1016/j.jsat.2007.10.003.
14. Buysse DJ, Frank E, Lowe KK, et al. Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol Psychiatry. 1997;41:406-418.
15. Buysse DJ, Germain A, Moul DE, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med. 2011;171(10):887-895. doi:10.1001/archinternmed.2010.535.
16. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213. doi:0165-1781(89)90047-4 [pii].
17. Carney CE, Buysse DJ, Ancoli-Israel S, et al. The consensus sleep diary: Standardizing prospective sleep self-monitoring. Sleep. 2012;35(2):287-302. doi:10.5665/sleep.1642.
18. Chesson AL Jr, Anderson WM, Littner M, et al. Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of theAmerican Academy of Sleep Medicine. Sleep. 1999;22:1128-1133.
19. CirauloDA, Nace EP.Benzodiazepine treatment of anxiety or insomnia in substance abuse patients. Am J Addict. 2000;9(4):276-279; discussion 280-274.
20. Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry. 1988;145(12):1501-1506.
21. Clark CP, Gillin JC, Golshan S, et al. Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression. Biol Psychiatry. 1998;43(8):601-607. doi:S0006-3223(97)00457-5 [pii].
22. Crum RM, Ford DE, Storr CL, et al. Association of sleep disturbance with chronicity and remission of alcohol dependence: Data from a populationbased prospective study. Alcohol Clin Exp Res. 2004;28(10):1533-1540. doi:00000374-200410000-00013 [pii].
23. Currie SR, Clark S, Hodgins DC, et al. Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics. Addiction. 2004;99(9):1121-1132. doi:10.1111/j.1360-0443.2004.00835.x ADD835 [pii].
24. Drummond SP, Gillin JC, Smith TL, et al. The sleep of abstinent pure primary alcoholic patients: Natural course and relationship to relapse. Alcohol Clin Exp Res. 1998;22(8):1796-1802. doi:00000374-199811000-00026 [pii].
25. Edinger JD, Wohlgemuth WK, Radtke RA, et al. Does cognitivebehavioral insomnia therapy alter dysfunctional beliefs about sleep? Sleep. 2001;24:591-599.
26. Erdogan S. [Quetiapine in substance use disorders, abuse and dependence possibility: A review]. Turk Psikiyatri Derg. 2010;21(2):167-175.
27. Evans SM, Funderburk FR, Griffiths RR. Zolpidem and triazolam in humans: Behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther. 1990;255(3):1246-1255.
28. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262(11):1479-1484.
29. Foster JH, Peters TJ. Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome. Alcohol Clin Exp Res. 1999;23(6):1044-1051. doi:00000374-199906000-00012 [pii].
30. Fox HC, Anderson GM, Tuit K, et al. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: Preliminary findings. Alcohol Clin Exp Res. 2012;36(2):351-360. doi:10.1111/j.1530-0277.2011.01628.x.
31. Friedmann PD, Herman DS, Freedman S, et al. Treatment of sleep disturbance in alcohol recovery: A national survey of addiction medicine physicians. J Addict Dis. 2003;22(2):91-103. doi:10.1300/J069v22n02-08.
32. Friedmann PD, Rose JS, Swift R, et al. Trazodone for sleep disturbance after alcohol detoxification: A double-blind, placebo-controlled trial. Alcohol Clin Exp Res. 2008;32(9):1652-1660. doi:ACER742 [pii] 10.1111/j.1530-0277.2008.00742.x.
33. Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry. 2005;66(suppl 9):31-41.
34. Griffiths RR, Sannerud CA, Ator NA, et al. Zolpidem behavioral pharmacology in baboons: Self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther. 1992;260(3):1199-1208.
35. Haario P, RahkonenO, LaaksonenM, et al. Bidirectional associations between insomnia symptoms and unhealthy behaviours. J Sleep Res. 2013;22(1):89-95. doi:10.1111/j.1365-2869.2012.01043.x.
36. Hoelscher TJ, Edinger JD. Treatment of sleep-maintenance insomnia in older adults: Sleep period reduction, sleep education, and modified stimulus control. Psychol Aging. 1988;3(3):258-263.
37. Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 2006;25:3-14.
38. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 1991;14:540-545.
39. Johnson EO, Breslau N. Sleep problems and substance use in adolescence. Drug Alcohol Depend. 2001;64(1):1-7.
40. Karam-Hage M, Brower KJ. Gabapentin treatment for insomnia associated with alcohol dependence. Am J Psychiatry. 2000;157(1):151.
41. Landolt HP, Gillin JC. Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management. CNS Drugs. 2001;15(5):413-425.
42. Manber R, Carney C, Edinger J, et al. Dissemination of CBTI to the non-sleep specialist: Protocol development and training issues. J Clin Sleep Med. 2012;8(2):209-218. doi:10.5664/jcsm.1786.
43. Monnelly EP, Ciraulo DA, Knapp C, et al. Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol. 2004;24(5):532-535.
44. Montgomery P, Dennis J. Cognitive-behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev. 2003;(1):CD003161.
45. Morin CM, Belleville G, Belanger L, et al. The insomnia severity index: Psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601-608.
46. Morin CM, Bootzin RR, Buysse DJ, et al. Psychological and behavioral treatment of insomnia: An update of recent evidence (1998-2004). Sleep. 2006;29:1396-1406.
47. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. Am J Psychiatry. 1994;151:1172-1180.
48. Morin CM, Espie CA. Insomnia: A Clinical Guide to Assessment and Treatment. New York: Kluwer Academic/Plenum; 2003.
49. Morin CM, Gaulier B, Barry T, et al. Patients' acceptance of psychological and pharmacological therapies for insomnia. Sleep. 1992;15:302-305.
50. Morin CM, Hauri PJ, Espie CA, et al. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep. 1999;22:1134-1156.
51. Morin CM, Vallieres A, Guay B, et al. Cognitive-behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial. JAMA. 2009;301(19):2005-2015. doi:301/19/2005[pii]10.1001/jama.2009.682.
52. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: A meta-analysis. J Consult Clin Psych. 1995;63:79-89. doi:10.1037/0022-006X.63.1.79.
53. Ohayon MM, Smirne S. Prevalence and consequences of insomnia disorders in the general population of Italy. Sleep Med. 2002;3(2):115-120. doi:S1389945701001587 [pii]
54. Pace-Schott EF, Stickgold R, Muzur A, et al. Sleep quality deteriorates over a binge-abstinence cycle in chronic smoked cocaine users. Psychopharmacol (Berl). 2005;179(4):873-883. doi:10.1007/s00213-004-2088-z.
55. Peles E, Schreiber S, Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend. 2006;82(2):103-110. doi:S0376-8716(05)00259-0 [pii]10.1016/j.drugalcdep.2005.08.011.
56. Ree M, Harvey AG. Insomnia. In: Bennett-Levy J, Butler G, Fennell M, et al., eds. Oxford Guide to Behavioural Experiments in Cognitive Therapy. Oxford, England: Oxford University Press; 2004: 287-305.
57. Roth T. Does effective management of sleep disorders reduce substance dependence? Drugs. 2009;69(suppl 2):65-75. doi:6 [pii] 10.2165/11531120-000000000-00000.
58. Roth T, Coulouvrat C, Hajak G, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: Results from the America Insomnia Survey. Biol Psychiatry. 2011;69(6):592-600. doi:S0006-3223(10)01154-6 [pii]10.1016/j.biopsych.2010.10.023.
59. Sattar SP, Bhatia SC, Petty F. Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci. 2004;29(6):452-457.
60. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: A randomized controlled trial. J Am Med Assoc. 2006;295:2851-2858.
61. Smith LJ, Nowakowski S, Soeffing JP, et al. The measurement of sleep. In: Perlis ML, Lichstein KL, eds. Treating Sleep Disorders: Principles and Practice of Behavioral Sleep Medicine. New York, NY: John Wiley & Sons Inc; 2003:29-73.
62. Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159(1):5-11.
63. Spielman AJ, Caruso LS, Glovinsky PB.Abehavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987a;10(4):541-553.
64. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987b;10(1):45-56.
65. Tassniyom K, Paholpak S, Tassniyom S, et al. Quetiapine for primary insomnia: A double blind, randomized controlled trial. J Med Assoc Thai. 2010;93(6):729-734.
66. Thomas A, Nallur DG, Jones N, et al. Diphenhydramine abuse and detoxification: A brief review and case report. J Psychopharmacol. 2009;23(1), 101-105. doi:10.1177/0269881107083809.
67. Walsh JK, Roehrs T, Roth T. Pharmacological treatment of primary insomnia. In: KrygerMH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:749-760.
68. Weissman MM, Greenwald S, Nino-Murcia G, et al. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry. 1997;19(4):245-250. doi:S016383439700056X [pii].
69. Wiegand MH, Landry F, Bruckner T, et al. Quetiapine in primary insomnia: A pilot study. Psychopharmacol (Berl). 2008;196(2):337-338. doi:10.1007/s00213-007-0968-8.